AWK vs CTKB · P/E 22, rev $4.65B vs rev $200.5M
American Water Works (AWK) versus Cytek Biosciences Inc (CTKB) — a side-by-side from cached financials, not a winner call.
American Water Works (AWK) is a utilities - regulated water company listed on US.
Cytek Biosciences Inc (CTKB) is a medical devices company listed on US.
Latest reported AWK revenue for 2024-12-31 was $4.65B. Net income was $239.0M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. AWK currently screens at market cap $24.31B and trailing P/E 22.1.
Latest reported CTKB revenue for 2024-12-31 was $200.5M. Net income was -$6.0M. Revenue was up 3.9% from 2023-12-31 to 2024-12-31. CTKB currently screens at market cap $421.8M.
AWK currently screens at market cap $24.31B and trailing P/E 22.1. CTKB currently screens at market cap $421.8M.
Not investment advice. Open the AWK and CTKB stock pages for the full models.
Not investment advice.